Works matching IS 16187598 AND DT 2023 AND VI 24 AND IP 6
Results: 12
Does competition improve hospital performance: a DEA based evaluation from the Netherlands.
- Published in:
- European Journal of Health Economics, 2023, v. 24, n. 6, p. 999, doi. 10.1007/s10198-022-01529-8
- By:
- Publication type:
- Article
Willingness to pay for health gains from an international integrated early warning system for infectious disease outbreaks.
- Published in:
- European Journal of Health Economics, 2023, v. 24, n. 6, p. 967, doi. 10.1007/s10198-022-01527-w
- By:
- Publication type:
- Article
The application of discrete choice experiments eliciting young peoples' preferences for healthcare: a systematic literature review.
- Published in:
- European Journal of Health Economics, 2023, v. 24, n. 6, p. 987, doi. 10.1007/s10198-022-01528-9
- By:
- Publication type:
- Article
The handling of missing data in trial-based economic evaluations: should data be multiply imputed prior to longitudinal linear mixed-model analyses?
- Published in:
- European Journal of Health Economics, 2023, v. 24, n. 6, p. 951, doi. 10.1007/s10198-022-01525-y
- By:
- Publication type:
- Article
Comparison of EQ-5D-5L and EORTC QLU-C10D utilities in gastric cancer patients.
- Published in:
- European Journal of Health Economics, 2023, v. 24, n. 6, p. 885, doi. 10.1007/s10198-022-01523-0
- By:
- Publication type:
- Article
Do mobile hospital teams in residential aged care facilities increase health care efficiency: an evaluation of French residential care policy.
- Published in:
- European Journal of Health Economics, 2023, v. 24, n. 6, p. 923, doi. 10.1007/s10198-022-01522-1
- By:
- Publication type:
- Article
Cost-effectiveness of adding oseltamivir to primary care for influenza-like-illness: economic evaluation alongside the randomised controlled ALIC<sup>4</sup>E trial in 15 European countries.
- Published in:
- European Journal of Health Economics, 2023, v. 24, n. 6, p. 909, doi. 10.1007/s10198-022-01521-2
- By:
- Publication type:
- Article
Using the EQ-5D-5L to investigate quality-of-life impacts of disease-modifying therapy policies for people with multiple sclerosis (MS) in New Zealand.
- Published in:
- European Journal of Health Economics, 2023, v. 24, n. 6, p. 939, doi. 10.1007/s10198-022-01518-x
- By:
- Publication type:
- Article
Completing the time trade-off with respondents who are older, in poorer health or with an immigrant background in an EQ-5D-5L valuation study.
- Published in:
- European Journal of Health Economics, 2023, v. 24, n. 6, p. 877, doi. 10.1007/s10198-022-01517-y
- By:
- Publication type:
- Article
Trends and drivers of pharmaceutical expenditures from systemic anti-cancer therapy.
- Published in:
- European Journal of Health Economics, 2023, v. 24, n. 6, p. 853, doi. 10.1007/s10198-022-01515-0
- By:
- Publication type:
- Article
The long-term cost-effectiveness of once-weekly semaglutide 1 mg vs. dulaglutide 3 mg and 4.5 mg in the UK.
- Published in:
- European Journal of Health Economics, 2023, v. 24, n. 6, p. 895, doi. 10.1007/s10198-022-01514-1
- By:
- Publication type:
- Article
Apixaban versus other anticoagulants in patients with nonvalvular fibrillation: a comparison of all-cause and event-related costs in real-life setting in France.
- Published in:
- European Journal of Health Economics, 2023, v. 24, n. 6, p. 867, doi. 10.1007/s10198-022-01513-2
- By:
- Publication type:
- Article